Meeting
2015 ASCO Annual Meeting
Multiplatform molecular profiling of pancreatic adenocarcinomas to identify BRCA1/2 mutations and PD-1/PD-L1 status with therapeutic implications.
Authors
Sherri Z. Millis
Caris Life Sciences, Phoenix, AZ
Sherri Z. Millis , Brian L. Abbott , Erin H Baker , Ryan Bender , Jeffrey Swensen , Zoran Gatalica , Sandeep K. Reddy , Alexander Rosemurgy , David A Iannitti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 4124)
DOI
10.1200/jco.2015.33.15_suppl.4124
Abstract #
4124
Poster Bd #
236
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Comparative molecular analyses of pancreatic cancer (PC): KRAS wild type vs. KRAS mutant tumors and primary tumors vs. distant metastases.
First Author: Mohamed E. Salem
Poster
2022 ASCO Annual Meeting
Mutational landscape of pancreatic adenocarcinoma identified by prospective clinical sequencing in a nationwide cancer network.
First Author: Katherine E Poruk
Poster
2017 ASCO Annual Meeting
Colorectal cancer: Impact of primary tumor location on genetic alterations.
First Author: Mohamed E. Salem
Poster
2016 ASCO Annual Meeting
Comparative molecular analyses of esophageal cancer: Adenocarcinoma vs. squamous cell carcinomas and impact on outcome.
First Author: Mohamed E. Salem